Background
David Rastall is a physician scientist and fellowship-trained neurologist specializing in neuro-visual and vestibular disorders. He diagnoses and treats patients with eye movement disorders and dizziness resulting from ataxia, cerebellar damage, brainstem damage, or peripheral vestibular lesions, with symptoms including vertigo, nystagmus, oscillopsia, diplopia and dizziness. Dr. Rastall helped develop and participates in the teledizzy initiative, a transformative approach to medicine incorporating data science and cutting-edge technologies including artificial intelligence, machine learning and counterfactual analysis to efficiently pair dizzy patients with emergencies at remote locations with world-leading Johns Hopkins vestibular neurologists. Among the procedures he offers are video-oculography, video head impulse test, quantitative sensory and motor testing for ocular alignment, photo funds evaluation and video ocular counter-roll evaluation.
Dr. Rastall obtained his doctorate in osteopathic medicine from Michigan State University College of Osteopathic Medicine, where he remained for residency training in neurology and ophthalmology. He underwent fellowship training in vestibular and ocular motor oto-neurology at the Johns Hopkins University School of Medicine.
Dr. Rastall’s research interests include developing machine learning and artificial intelligence approaches to increase diagnostic accuracy of eye movement disorders, chronic dizziness, and neurodegenerative disorders; developing medical “spy-ware" to allow passive, interaction-free longitudinal patient measurements; and creation of an eye movement and behavioral “behaviorome" in healthy aging and neurodegeneration. He is also interested in ocular motor phenotyping of healthy aging, neurodegeneration and cerebellar disease.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.